| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
Jenna Brashear
Rosalio Madrigal
Michael Rose
Jenna Brashear
| Share Statistics | CNTB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $138.8 | $271.6 | 24% |
|
| Shares Out (Mil) | 56.5 | 51.2 | 51% |
|
| Institutional Ownership | 52.5% | 92.3% | 37% |
|
| Float (Mil) | 18.9 | 39.8 | 28% |
|
| Beta | na | 0.93 | na |
|
| Avg Daily Volume (000s) | 290 | 489 | 49% |
|
| Price Change (52-week) |
na | 57.7% | na |
|
| Growth | CNTB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | 14.2% | (10.1%) | 61% |
|
| EPS (5yr) | 32.2% | 16.0% | 83 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.1%) | (15.6%) | 51% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CNTB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $37 | 0% |
|
| Net Income (TTM) (Mil) | ($65) | ($44) | 14% |
|
| EPS (TTM) | ($1.155) | ($1.600) | 20% |
|
| Operating Cash Flow (TTM) (Mil) | ($57) | ($31) | 9% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $3 | 39% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 13% |
|
| Enterprise Value (Q1) (Mil) | $102 | $190 | 22% |
|
| Valuation | CNTB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.24 | 2.82 | 66% |
|
| P/E | na | 19.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | CNTB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 63.8% | 96% |
|
| Net Margin | na | (70.6%) | na |
|
| ROA | (84.6%) | (49.3%) | 7% |
|
| ROE | (102.9%) | (58.1%) | 9% |
|
| Liabilities to Assets | 29.0% | 30.5% | 20% |
|
| F-Score | 1 | 3 | 1% |
|
Connect Biopharma Holdings Limited did not pass any screens on 8/7/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
